0Q4U.LSE

Novozymes A/S B

0Q4U.LSE, UK

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Lyngby, Denmark.

https://www.novonesis.com

Stock Price

DKK0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A

Finn Analysis

(Last Updated 2023-06-30)

Health Score

Investors

* Institutions hold a combined 0.00% of the total shares of Novozymes A/S B

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

2.2117

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2023-06-30)

Deep Value
Weak Deep Value(0.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(1.5)
GARP
Not Attractive for GARP(0)
Growth
Weak Growth Prospect(0)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(0)
Quality
Low Quality Business(0.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2023-06-30)

Revenue

DKK 0

Cost Of Revenue

DKK 0

Gross Profit

DKK 0

Operating Expenses

DKK 0

Operating Income

DKK 0

Interest Expense

DKK 0

Pretax Income

DKK 0

Net Income

DKK 0

Income Tax Expense

DKK 0

EBITDA

DKK 0

Total Other Income Expense Net

DKK 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2023-06-30)

Cash

DKK 0

Short Term Investments

DKK 0

Receivables

DKK 0

Inventories

DKK 0

Total Current Assets

DKK 0

Property Plant Equipment

DKK 0

Total Assets

DKK 0

Payables

DKK 0

Short Term Debt

DKK 0

Long Term Debt

DKK 0

Total Liabilities

DKK 0

Equity

DKK 0

Trend

Cash Flow

(Last Updated 2023-06-30)

Net Income

DKK 0

Depreciation

DKK 0

Change In Working Capital

DKK 0

Cash From Operations

DKK 0

Capital Expenditures

DKK 0

Cash From Investing

DKK 0

Cash From Financing

DKK 0

Net Change In Cash

DKK 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.